Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers.

PLoS Clin Trials · 2007 · PMC1764434 · PMID 17213921

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

of borderline significancep = 0.09so close (0.05 < p ≤ 0.1)

In the comparison of the 1,500 mg therapeutic dose of CQ with 1,750 mg AQ-13, the 1,750 mg AQ-13 dose produced a smaller AUC τ than 1,500 mg CQ, although this difference was of borderline significance ( p = 0.09; Table 4 ).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.